RU2014120208A - COMPREHENSIVE ANTIBACTERIAL COMPOSITION FOR ANIMALS - Google Patents
COMPREHENSIVE ANTIBACTERIAL COMPOSITION FOR ANIMALS Download PDFInfo
- Publication number
- RU2014120208A RU2014120208A RU2014120208A RU2014120208A RU2014120208A RU 2014120208 A RU2014120208 A RU 2014120208A RU 2014120208 A RU2014120208 A RU 2014120208A RU 2014120208 A RU2014120208 A RU 2014120208A RU 2014120208 A RU2014120208 A RU 2014120208A
- Authority
- RU
- Russia
- Prior art keywords
- infectious disease
- animals
- composition
- enrofloxacin
- sulfamethoxazole
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims abstract 7
- 239000000203 mixture Substances 0.000 title claims abstract 7
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 208000035473 Communicable disease Diseases 0.000 claims abstract 8
- 208000015181 infectious disease Diseases 0.000 claims abstract 8
- 239000003814 drug Substances 0.000 claims abstract 6
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 claims abstract 4
- 210000002249 digestive system Anatomy 0.000 claims abstract 4
- 229960000740 enrofloxacin Drugs 0.000 claims abstract 4
- 210000002345 respiratory system Anatomy 0.000 claims abstract 4
- 229960005404 sulfamethoxazole Drugs 0.000 claims abstract 4
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 claims abstract 4
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims abstract 4
- 229960001082 trimethoprim Drugs 0.000 claims abstract 4
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 claims abstract 2
- 241000894006 Bacteria Species 0.000 claims abstract 2
- 241000588807 Bordetella Species 0.000 claims abstract 2
- 241000588724 Escherichia coli Species 0.000 claims abstract 2
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 claims abstract 2
- 241000606856 Pasteurella multocida Species 0.000 claims abstract 2
- 241000607142 Salmonella Species 0.000 claims abstract 2
- 239000004480 active ingredient Substances 0.000 claims abstract 2
- 230000000845 anti-microbial effect Effects 0.000 claims abstract 2
- 239000008187 granular material Substances 0.000 claims abstract 2
- 238000002347 injection Methods 0.000 claims abstract 2
- 239000007924 injection Substances 0.000 claims abstract 2
- 239000007788 liquid Substances 0.000 claims abstract 2
- 239000002674 ointment Substances 0.000 claims abstract 2
- 229940051027 pasteurella multocida Drugs 0.000 claims abstract 2
- 239000006187 pill Substances 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims abstract 2
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1. Антимикробная композиция для животных, содержащая 10-35 мас.% энрофлоксацина, 5-25 мас.% триметоприма и 40-80 мас.% сульфаметоксазола.2. Композиция по п. 1, где массовое отношение энрофлоксацин:триметоприм:сульфаметоксазол составляет 2:1:5.3. Лекарственное средство для животных для лечения инфекционного заболевания пищеварительной системы или инфекционного заболевания дыхательной системы у животных, содержащее композицию по п. 1 или 2 в качестве активного ингредиента.4. Лекарственное средство по п. 3, изготовленное в форме порошка, пилюли, гранулы, жидкости, раствора для инъекций или мази.5. Лекарственное средство по п. 3, где инфекционное заболевание пищеварительной системы или инфекционное заболевание дыхательной системы вызвано одной или более бактериями, выбранными из группы, состоящей из Escherichia coli, Salmonella spp., Mycoplasma hyopneumoniae, Pasteurella multocida, Actinobacillus pleuropneumoniae, Bordetella bronchseptica и Staphylococcus aureus.1. Antimicrobial composition for animals, containing 10-35 wt.% Enrofloxacin, 5-25 wt.% Trimethoprim and 40-80 wt.% Sulfamethoxazole. 2. The composition according to claim 1, where the mass ratio of enrofloxacin: trimethoprim: sulfamethoxazole is 2: 1: 5.3. An animal medicine for treating an infectious disease of the digestive system or an infectious disease of the respiratory system in animals containing the composition of claim 1 or 2 as an active ingredient. 4. The medicament according to claim 3, made in the form of a powder, pill, granule, liquid, injection or ointment. The medicament according to claim 3, wherein the infectious disease of the digestive system or the infectious disease of the respiratory system is caused by one or more bacteria selected from the group consisting of Escherichia coli, Salmonella spp., Mycoplasma hyopneumoniae, Pasteurella multocida, Actinobacillus pleuropneumoniae, Bordetella bronchylseptus bronchelseclseptus .
Claims (5)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110128657A KR101396933B1 (en) | 2011-12-02 | 2011-12-02 | The composition of antibacterial complex for animal |
| KR10-2011-0128657 | 2011-12-02 | ||
| PCT/KR2012/007595 WO2013081284A1 (en) | 2011-12-02 | 2012-09-21 | Complex antibacterial composition for animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2014120208A true RU2014120208A (en) | 2016-02-10 |
Family
ID=48535699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014120208A RU2014120208A (en) | 2011-12-02 | 2012-09-21 | COMPREHENSIVE ANTIBACTERIAL COMPOSITION FOR ANIMALS |
Country Status (6)
| Country | Link |
|---|---|
| KR (1) | KR101396933B1 (en) |
| CN (1) | CN103945847B (en) |
| BR (1) | BR112014013242A2 (en) |
| PH (1) | PH12014501104B1 (en) |
| RU (1) | RU2014120208A (en) |
| WO (1) | WO2013081284A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104606207A (en) * | 2015-02-09 | 2015-05-13 | 南京格耀生物科技有限公司 | Application of sulfamethoxazole in preparing medicament for inhibiting tumor cell metastasis and diffusion |
| KR102489659B1 (en) | 2020-07-20 | 2023-01-18 | 경북대학교 산학협력단 | Composition of antimicrobial complex for animal comprising amphenicols and aminoglycosides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR860000502B1 (en) * | 1980-09-10 | 1986-05-02 | 후나이 야꾸힝 고오교 가부시끼 가이샤 | Process for preparing tablets containing anti-biotic substance |
| US20070086954A1 (en) * | 1998-11-23 | 2007-04-19 | Miller Christopher C | Method and apparatus for treatment of respiratory infections by nitric oxide inhalation |
| KR100371092B1 (en) * | 1999-12-09 | 2003-02-05 | 주식회사대성미생물연구소 | The composition of antibacterial complex for animal |
| CN101011402A (en) * | 2007-02-06 | 2007-08-08 | 天津生机集团有限公司 | Compound sulfadimidine sodium injection and its preparation method |
-
2011
- 2011-12-02 KR KR1020110128657A patent/KR101396933B1/en active IP Right Grant
-
2012
- 2012-09-21 RU RU2014120208A patent/RU2014120208A/en unknown
- 2012-09-21 BR BR112014013242A patent/BR112014013242A2/en not_active IP Right Cessation
- 2012-09-21 CN CN201280056185.7A patent/CN103945847B/en active Active
- 2012-09-21 WO PCT/KR2012/007595 patent/WO2013081284A1/en active Application Filing
-
2014
- 2014-05-16 PH PH12014501104A patent/PH12014501104B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103945847B (en) | 2016-04-13 |
| PH12014501104A1 (en) | 2014-08-11 |
| KR20130062187A (en) | 2013-06-12 |
| KR101396933B1 (en) | 2014-05-21 |
| BR112014013242A2 (en) | 2017-06-13 |
| WO2013081284A1 (en) | 2013-06-06 |
| CN103945847A (en) | 2014-07-23 |
| PH12014501104B1 (en) | 2014-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20130928T1 (en) | C7-fluoro substituted tetracycline compounds | |
| BR112013003045A2 (en) | compound and pharmaceutical composition and uses thereof, sterile container and method for preparing pharmaceutical composition for administration | |
| CN102205126B (en) | Application of combined catechin matters together with antibacterial agents | |
| WO2007148919A8 (en) | Bacteriophage having killing activity specific to staphylococcus aureus | |
| RU2014120208A (en) | COMPREHENSIVE ANTIBACTERIAL COMPOSITION FOR ANIMALS | |
| JP2024009968A5 (en) | ||
| RU2014140227A (en) | FULVIC ACID COMBINATION AND ANTIBIOTICS TO SUPPRESS THE GROWTH OF BACTERIA RESISTANT TO MANY MEDICINES, OR TREATMENT OF INFECTIONS CAUSED BY THEM | |
| CN102038668A (en) | Lauric acid diethanolamide and application of analog thereof | |
| EA201892278A1 (en) | ANBITACTERIAL BIAROMATIC DERIVATIVES WITH OXETHANE-3-ILOXY SUBSTITUTION | |
| RU2535092C1 (en) | Method of therapy of endometritis of cats and dogs | |
| CN103356663A (en) | Sulfamonomethoxine-ciprofloxacin-fosfomycin combined injection for veterinary use and preparation method thereof | |
| RU2560674C1 (en) | All-purpose antibacterial agent | |
| CN107898801A (en) | Composition and its application containing rifamycin and lipiarmycin | |
| RU2561589C2 (en) | Method of treating pneumonia in piglets | |
| Hossain et al. | Antibiofilm activity of Andrographis paniculata, Andrographolide and its derivatives: A Systematic Review | |
| RU2543349C1 (en) | Method of treatment of pneumonia of piglets | |
| CN102872105B (en) | Application of Houttuynoid C in antibacterial medicine | |
| CN103462968A (en) | Application of Incarviatone A in antibacterial medicaments | |
| CN103446114A (en) | Applications of Sarcaboside A in antibacterial medicament | |
| Samtsov et al. | Application of external drugs comprising silver compounds for the treatment of pyodermic patients | |
| Tischenko | Features of the antimicrobial action of plant essential oils on the opportunistic microflora | |
| BR112023002060A2 (en) | ANTIMICROBIAL PEPTIDOMIMETICS | |
| RU2491922C1 (en) | Method for increasing biocidal and therapeutic action of suspension-cream with enrofloxacin | |
| BR102019002370B1 (en) | POLYMER FILM BASED ON CHITOSAN AND ZEIN CONTAINING ELAGIC ACID | |
| CN101590067A (en) | A kind of otitis media compound preparation that is applicable to the dog class |